Global Assisted Reproductive Technologies Drugs Supply, Demand and Key Producers, 2023-2029

January 2023 | 113 pages | ID: GDA050334BD5EN
GlobalInfoResearch

Abstracts

Assisted reproductive technology (ART) is used to treat infertility. It includes fertility treatments that handle both eggs and sperm. A number of different agents are used to achieve controlled ovarian hyperstimulation. These include clomiphene, GnRH analogues, menotropins, urofollitropin, highly purified FSH, and recombinant human FSH (rh-FSH), etc.

This report studies the global Assisted Reproductive Technologies Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Assisted Reproductive Technologies Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Assisted Reproductive Technologies Drugs that contribute to its increasing demand across many markets.

The global Assisted Reproductive Technologies Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study

Global Assisted Reproductive Technologies Drugs total market, 2018-2029, (USD Million)

Global Assisted Reproductive Technologies Drugs total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Assisted Reproductive Technologies Drugs total market, key domestic companies and share, (USD Million)

Global Assisted Reproductive Technologies Drugs revenue by player and market share 2018-2023, (USD Million)

Global Assisted Reproductive Technologies Drugs total market by Type, CAGR, 2018-2029, (USD Million)

Global Assisted Reproductive Technologies Drugs total market by Channel, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Assisted Reproductive Technologies Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, MSD, Ipsen, Ferring, Organon, Solvay, Besins, Zhejiang Xianju and Changchun GeneScience, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Assisted Reproductive Technologies Drugs market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Channel. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Assisted Reproductive Technologies Drugs Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Assisted Reproductive Technologies Drugs Market, Segmentation by Type

• Down-Regulation Drugs
• Ovulation Stimulation Drugs
• Ovulation Inducing Drugs
• Luteal Support Medications

Global Assisted Reproductive Technologies Drugs Market, Segmentation by Channel

• Hospital Pharmacy
• Specialty & Retail Pharmacy
• Online Pharmacy

Companies Profiled:

• Merck
• MSD
• Ipsen
• Ferring
• Organon
• Solvay
• Besins
• Zhejiang Xianju
• Changchun GeneScience
• Hybio Pharmaceutical
• Livzon Pharmaceutical

Key Questions Answered

1. How big is the global Assisted Reproductive Technologies Drugs market?

2. What is the demand of the global Assisted Reproductive Technologies Drugs market?

3. What is the year over year growth of the global Assisted Reproductive Technologies Drugs market?

4. What is the total value of the global Assisted Reproductive Technologies Drugs market?

5. Who are the major players in the global Assisted Reproductive Technologies Drugs market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Assisted Reproductive Technologies Drugs Introduction
1.2 World Assisted Reproductive Technologies Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Assisted Reproductive Technologies Drugs Total Market by Region (by Headquarter Location)
  1.3.1 World Assisted Reproductive Technologies Drugs Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Assisted Reproductive Technologies Drugs Market Size (2018-2029)
  1.3.3 China Assisted Reproductive Technologies Drugs Market Size (2018-2029)
  1.3.4 Europe Assisted Reproductive Technologies Drugs Market Size (2018-2029)
  1.3.5 Japan Assisted Reproductive Technologies Drugs Market Size (2018-2029)
  1.3.6 South Korea Assisted Reproductive Technologies Drugs Market Size (2018-2029)
  1.3.7 ASEAN Assisted Reproductive Technologies Drugs Market Size (2018-2029)
  1.3.8 India Assisted Reproductive Technologies Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Assisted Reproductive Technologies Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Assisted Reproductive Technologies Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Assisted Reproductive Technologies Drugs Consumption Value (2018-2029)
2.2 World Assisted Reproductive Technologies Drugs Consumption Value by Region
  2.2.1 World Assisted Reproductive Technologies Drugs Consumption Value by Region (2018-2023)
  2.2.2 World Assisted Reproductive Technologies Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Assisted Reproductive Technologies Drugs Consumption Value (2018-2029)
2.4 China Assisted Reproductive Technologies Drugs Consumption Value (2018-2029)
2.5 Europe Assisted Reproductive Technologies Drugs Consumption Value (2018-2029)
2.6 Japan Assisted Reproductive Technologies Drugs Consumption Value (2018-2029)
2.7 South Korea Assisted Reproductive Technologies Drugs Consumption Value (2018-2029)
2.8 ASEAN Assisted Reproductive Technologies Drugs Consumption Value (2018-2029)
2.9 India Assisted Reproductive Technologies Drugs Consumption Value (2018-2029)

3 WORLD ASSISTED REPRODUCTIVE TECHNOLOGIES DRUGS COMPANIES COMPETITIVE ANALYSIS

3.1 World Assisted Reproductive Technologies Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Assisted Reproductive Technologies Drugs Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Assisted Reproductive Technologies Drugs in 2022
  3.2.3 Global Concentration Ratios (CR8) for Assisted Reproductive Technologies Drugs in 2022
3.3 Assisted Reproductive Technologies Drugs Company Evaluation Quadrant
3.4 Assisted Reproductive Technologies Drugs Market: Overall Company Footprint Analysis
  3.4.1 Assisted Reproductive Technologies Drugs Market: Region Footprint
  3.4.2 Assisted Reproductive Technologies Drugs Market: Company Product Type Footprint
  3.4.3 Assisted Reproductive Technologies Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Assisted Reproductive Technologies Drugs Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Assisted Reproductive Technologies Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Assisted Reproductive Technologies Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Assisted Reproductive Technologies Drugs Consumption Value Comparison
  4.2.1 United States VS China: Assisted Reproductive Technologies Drugs Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Assisted Reproductive Technologies Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Assisted Reproductive Technologies Drugs Companies and Market Share, 2018-2023
  4.3.1 United States Based Assisted Reproductive Technologies Drugs Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Assisted Reproductive Technologies Drugs Revenue, (2018-2023)
4.4 China Based Companies Assisted Reproductive Technologies Drugs Revenue and Market Share, 2018-2023
  4.4.1 China Based Assisted Reproductive Technologies Drugs Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Assisted Reproductive Technologies Drugs Revenue, (2018-2023)
4.5 Rest of World Based Assisted Reproductive Technologies Drugs Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Assisted Reproductive Technologies Drugs Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Assisted Reproductive Technologies Drugs Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Assisted Reproductive Technologies Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Down-Regulation Drugs
  5.2.2 Ovulation Stimulation Drugs
  5.2.3 Ovulation Inducing Drugs
  5.2.4 Luteal Support Medications
5.3 Market Segment by Type
  5.3.1 World Assisted Reproductive Technologies Drugs Market Size by Type (2018-2023)
  5.3.2 World Assisted Reproductive Technologies Drugs Market Size by Type (2024-2029)
  5.3.3 World Assisted Reproductive Technologies Drugs Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY CHANNEL

6.1 World Assisted Reproductive Technologies Drugs Market Size Overview by Channel: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Channel
  6.2.1 Hospital Pharmacy
  6.2.2 Specialty & Retail Pharmacy
  6.2.3 Online Pharmacy
6.3 Market Segment by Channel
  6.3.1 World Assisted Reproductive Technologies Drugs Market Size by Channel (2018-2023)
  6.3.2 World Assisted Reproductive Technologies Drugs Market Size by Channel (2024-2029)
  6.3.3 World Assisted Reproductive Technologies Drugs Market Size by Channel (2018-2029)

7 COMPANY PROFILES

7.1 Merck
  7.1.1 Merck Details
  7.1.2 Merck Major Business
  7.1.3 Merck Assisted Reproductive Technologies Drugs Product and Services
  7.1.4 Merck Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Merck Recent Developments/Updates
  7.1.6 Merck Competitive Strengths & Weaknesses
7.2 MSD
  7.2.1 MSD Details
  7.2.2 MSD Major Business
  7.2.3 MSD Assisted Reproductive Technologies Drugs Product and Services
  7.2.4 MSD Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 MSD Recent Developments/Updates
  7.2.6 MSD Competitive Strengths & Weaknesses
7.3 Ipsen
  7.3.1 Ipsen Details
  7.3.2 Ipsen Major Business
  7.3.3 Ipsen Assisted Reproductive Technologies Drugs Product and Services
  7.3.4 Ipsen Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Ipsen Recent Developments/Updates
  7.3.6 Ipsen Competitive Strengths & Weaknesses
7.4 Ferring
  7.4.1 Ferring Details
  7.4.2 Ferring Major Business
  7.4.3 Ferring Assisted Reproductive Technologies Drugs Product and Services
  7.4.4 Ferring Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Ferring Recent Developments/Updates
  7.4.6 Ferring Competitive Strengths & Weaknesses
7.5 Organon
  7.5.1 Organon Details
  7.5.2 Organon Major Business
  7.5.3 Organon Assisted Reproductive Technologies Drugs Product and Services
  7.5.4 Organon Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Organon Recent Developments/Updates
  7.5.6 Organon Competitive Strengths & Weaknesses
7.6 Solvay
  7.6.1 Solvay Details
  7.6.2 Solvay Major Business
  7.6.3 Solvay Assisted Reproductive Technologies Drugs Product and Services
  7.6.4 Solvay Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Solvay Recent Developments/Updates
  7.6.6 Solvay Competitive Strengths & Weaknesses
7.7 Besins
  7.7.1 Besins Details
  7.7.2 Besins Major Business
  7.7.3 Besins Assisted Reproductive Technologies Drugs Product and Services
  7.7.4 Besins Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Besins Recent Developments/Updates
  7.7.6 Besins Competitive Strengths & Weaknesses
7.8 Zhejiang Xianju
  7.8.1 Zhejiang Xianju Details
  7.8.2 Zhejiang Xianju Major Business
  7.8.3 Zhejiang Xianju Assisted Reproductive Technologies Drugs Product and Services
  7.8.4 Zhejiang Xianju Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Zhejiang Xianju Recent Developments/Updates
  7.8.6 Zhejiang Xianju Competitive Strengths & Weaknesses
7.9 Changchun GeneScience
  7.9.1 Changchun GeneScience Details
  7.9.2 Changchun GeneScience Major Business
  7.9.3 Changchun GeneScience Assisted Reproductive Technologies Drugs Product and Services
  7.9.4 Changchun GeneScience Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Changchun GeneScience Recent Developments/Updates
  7.9.6 Changchun GeneScience Competitive Strengths & Weaknesses
7.10 Hybio Pharmaceutical
  7.10.1 Hybio Pharmaceutical Details
  7.10.2 Hybio Pharmaceutical Major Business
  7.10.3 Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Product and Services
  7.10.4 Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Hybio Pharmaceutical Recent Developments/Updates
  7.10.6 Hybio Pharmaceutical Competitive Strengths & Weaknesses
7.11 Livzon Pharmaceutical
  7.11.1 Livzon Pharmaceutical Details
  7.11.2 Livzon Pharmaceutical Major Business
  7.11.3 Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Product and Services
  7.11.4 Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Livzon Pharmaceutical Recent Developments/Updates
  7.11.6 Livzon Pharmaceutical Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Assisted Reproductive Technologies Drugs Industry Chain
8.2 Assisted Reproductive Technologies Drugs Upstream Analysis
8.3 Assisted Reproductive Technologies Drugs Midstream Analysis
8.4 Assisted Reproductive Technologies Drugs Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Assisted Reproductive Technologies Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Assisted Reproductive Technologies Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Assisted Reproductive Technologies Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Assisted Reproductive Technologies Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Assisted Reproductive Technologies Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Assisted Reproductive Technologies Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Assisted Reproductive Technologies Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Assisted Reproductive Technologies Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Assisted Reproductive Technologies Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Assisted Reproductive Technologies Drugs Players in 2022
Table 12. World Assisted Reproductive Technologies Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Assisted Reproductive Technologies Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Assisted Reproductive Technologies Drugs Player
Table 15. Assisted Reproductive Technologies Drugs Market: Company Product Type Footprint
Table 16. Assisted Reproductive Technologies Drugs Market: Company Product Application Footprint
Table 17. Assisted Reproductive Technologies Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Assisted Reproductive Technologies Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Assisted Reproductive Technologies Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Assisted Reproductive Technologies Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Assisted Reproductive Technologies Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Assisted Reproductive Technologies Drugs Revenue Market Share (2018-2023)
Table 23. China Based Assisted Reproductive Technologies Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Assisted Reproductive Technologies Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Assisted Reproductive Technologies Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Assisted Reproductive Technologies Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Assisted Reproductive Technologies Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Assisted Reproductive Technologies Drugs Revenue Market Share (2018-2023)
Table 29. World Assisted Reproductive Technologies Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Assisted Reproductive Technologies Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Assisted Reproductive Technologies Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Assisted Reproductive Technologies Drugs Market Size by Channel, (USD Million), 2018 & 2022 & 2029
Table 33. World Assisted Reproductive Technologies Drugs Market Size by Channel (2018-2023) & (USD Million)
Table 34. World Assisted Reproductive Technologies Drugs Market Size by Channel (2024-2029) & (USD Million)
Table 35. Merck Basic Information, Area Served and Competitors
Table 36. Merck Major Business
Table 37. Merck Assisted Reproductive Technologies Drugs Product and Services
Table 38. Merck Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Merck Recent Developments/Updates
Table 40. Merck Competitive Strengths & Weaknesses
Table 41. MSD Basic Information, Area Served and Competitors
Table 42. MSD Major Business
Table 43. MSD Assisted Reproductive Technologies Drugs Product and Services
Table 44. MSD Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. MSD Recent Developments/Updates
Table 46. MSD Competitive Strengths & Weaknesses
Table 47. Ipsen Basic Information, Area Served and Competitors
Table 48. Ipsen Major Business
Table 49. Ipsen Assisted Reproductive Technologies Drugs Product and Services
Table 50. Ipsen Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Ipsen Recent Developments/Updates
Table 52. Ipsen Competitive Strengths & Weaknesses
Table 53. Ferring Basic Information, Area Served and Competitors
Table 54. Ferring Major Business
Table 55. Ferring Assisted Reproductive Technologies Drugs Product and Services
Table 56. Ferring Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Ferring Recent Developments/Updates
Table 58. Ferring Competitive Strengths & Weaknesses
Table 59. Organon Basic Information, Area Served and Competitors
Table 60. Organon Major Business
Table 61. Organon Assisted Reproductive Technologies Drugs Product and Services
Table 62. Organon Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Organon Recent Developments/Updates
Table 64. Organon Competitive Strengths & Weaknesses
Table 65. Solvay Basic Information, Area Served and Competitors
Table 66. Solvay Major Business
Table 67. Solvay Assisted Reproductive Technologies Drugs Product and Services
Table 68. Solvay Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Solvay Recent Developments/Updates
Table 70. Solvay Competitive Strengths & Weaknesses
Table 71. Besins Basic Information, Area Served and Competitors
Table 72. Besins Major Business
Table 73. Besins Assisted Reproductive Technologies Drugs Product and Services
Table 74. Besins Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Besins Recent Developments/Updates
Table 76. Besins Competitive Strengths & Weaknesses
Table 77. Zhejiang Xianju Basic Information, Area Served and Competitors
Table 78. Zhejiang Xianju Major Business
Table 79. Zhejiang Xianju Assisted Reproductive Technologies Drugs Product and Services
Table 80. Zhejiang Xianju Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Zhejiang Xianju Recent Developments/Updates
Table 82. Zhejiang Xianju Competitive Strengths & Weaknesses
Table 83. Changchun GeneScience Basic Information, Area Served and Competitors
Table 84. Changchun GeneScience Major Business
Table 85. Changchun GeneScience Assisted Reproductive Technologies Drugs Product and Services
Table 86. Changchun GeneScience Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Changchun GeneScience Recent Developments/Updates
Table 88. Changchun GeneScience Competitive Strengths & Weaknesses
Table 89. Hybio Pharmaceutical Basic Information, Area Served and Competitors
Table 90. Hybio Pharmaceutical Major Business
Table 91. Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Product and Services
Table 92. Hybio Pharmaceutical Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Hybio Pharmaceutical Recent Developments/Updates
Table 94. Livzon Pharmaceutical Basic Information, Area Served and Competitors
Table 95. Livzon Pharmaceutical Major Business
Table 96. Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Product and Services
Table 97. Livzon Pharmaceutical Assisted Reproductive Technologies Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Assisted Reproductive Technologies Drugs Upstream (Raw Materials)
Table 99. Assisted Reproductive Technologies Drugs Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Assisted Reproductive Technologies Drugs Picture
Figure 2. World Assisted Reproductive Technologies Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Assisted Reproductive Technologies Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Assisted Reproductive Technologies Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Assisted Reproductive Technologies Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Assisted Reproductive Technologies Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Assisted Reproductive Technologies Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Assisted Reproductive Technologies Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Assisted Reproductive Technologies Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Assisted Reproductive Technologies Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Assisted Reproductive Technologies Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Assisted Reproductive Technologies Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Assisted Reproductive Technologies Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Assisted Reproductive Technologies Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Assisted Reproductive Technologies Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Assisted Reproductive Technologies Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Assisted Reproductive Technologies Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Assisted Reproductive Technologies Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Assisted Reproductive Technologies Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Assisted Reproductive Technologies Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Assisted Reproductive Technologies Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Assisted Reproductive Technologies Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Assisted Reproductive Technologies Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Assisted Reproductive Technologies Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Assisted Reproductive Technologies Drugs Markets in 2022
Figure 27. United States VS China: Assisted Reproductive Technologies Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Assisted Reproductive Technologies Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Assisted Reproductive Technologies Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Assisted Reproductive Technologies Drugs Market Size Market Share by Type in 2022
Figure 31. Down-Regulation Drugs
Figure 32. Ovulation Stimulation Drugs
Figure 33. Ovulation Inducing Drugs
Figure 34. Luteal Support Medications
Figure 35. World Assisted Reproductive Technologies Drugs Market Size Market Share by Type (2018-2029)
Figure 36. World Assisted Reproductive Technologies Drugs Market Size by Channel, (USD Million), 2018 & 2022 & 2029
Figure 37. World Assisted Reproductive Technologies Drugs Market Size Market Share by Channel in 2022
Figure 38. Hospital Pharmacy
Figure 39. Specialty & Retail Pharmacy
Figure 40. Online Pharmacy
Figure 41. Assisted Reproductive Technologies Drugs Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source